How Antimicrobial Resistance Threatens Neonatal Mortality Rates Globally

Updated Dec 3, 2024 | 11:34 AM IST

SummaryNeonatal mortality remains a global concern, with neonatal sepsis and antimicrobial resistance (AMR) posing significant challenges. Combating AMR through infection control, responsible antibiotic use, and improved neonatal care is critical for reducing deaths.
How Antimicrobial Resistance Threatens Neonatal Mortality Rates Globally

How Antimicrobial Resistance Threatens Neonatal Mortality Rates Globally

Neonatal mortality remains a major health challenge across the world, which involves neonatal sepsis and other related factors of prematurity. Though many strides have been done in reducing NMR, there is a need for more appropriate interventions and strategies directed towards addressing the rise in the escalation of AMR. Combating AMR will be critical in improving neonatal survival rates while giving each newborn a healthier start into life globally.

The newborn period is the key period for infant health, and the first 28 days of life are critically important-both for survival and as a base to set lifetime health and development. Neonatal deaths globally have witnessed a significant decline over the past couple of decades. The neonatal mortality count has significantly reduced dropping from a high of 5 million in 1990 to as low as 2.3 million as of 2022. However, this decline notwithstanding, neonatal mortality is still staggeringly high across low-and middle-income nations.

Neonatal mortality rates are 22 per 1000 live births in India. Neonatal sepsis and prematurity are the main causes of neonatal deaths in these tragic events. Recognizing the gravity of the issue the Indian government started the Indian Newborn Action Plan (INAP) in 2014. The goal is to take NMR down to the single digits by 2030. This initiative has brought in several key interventions, including antenatal care (vaccines, micronutrient supplementation), skilled birth attendance, clean birth practices, and neonatal resuscitation techniques. More promisingly, postnatal interventions, including early initiation of breastfeeding and skin-to-skin contact, have been proven to work well in improving newborn survival rates.

Despite these improvements, one of the biggest concerns in neonatal care today is the growing problem of antimicrobial resistance (AMR) which seriously threatens efforts to reduce neonatal mortality.

What is Antimicrobial Resistance?

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses and fungi evolve over time and become resistant to commonly used antibiotics and other medications. This resistance makes infections more difficult to treat, increasing the risk of mortality and complicating treatment options. The World Health Organization has classified AMR as one of the most urgent global health threats since it not only causes death and disability but also places immense pressure on healthcare systems, significantly raising the economic burden.

The sources of AMR are many, including poor hygiene and infection control in healthcare settings, overuse and misuse of antibiotics. Contributing factors to this rapidly growing problem are antibiotic prescriptions for patient needs that do not require them and failure to complete antibiotic courses, as prescribed.

AMR and Newborn Health

For neonates, the risk is much more vital for AMR. Neonates are particularly prone to developing infections due to their rather weak immune systems. Neonatal sepsis, severe bacterial infection, is one of the leading causes of neonate deaths and it often manifests complications when it is because of drug-resistant pathogens.

According to Dr. Apoorva Taduri, Consultant Neonatologist, "Neonatal sepsis accounts for a significant proportion of neonatal deaths, and AMR is making it worse. MDR pathogens cause around 30% of neonatal sepsis mortality globally.

Maternal health and care are also factors influencing AMR in neonates. Over-prescription of antibiotics during pregnancy increases the risk of neonatal sepsis and the development of multi-drug-resistant pathogens in newborns. This calls for prudent use of antibiotics during pregnancy and at the time of delivery. In fact, studies indicate that indiscriminate use of antibiotics in mothers has a direct impact on neonatal health, which may eventually lead to resistant infections in newborns.

One of the major issues is that the drug-resistant bacteria are causing an increasing number of healthcare-associated infections in the neonatal care settings, which include NICUs. Infections by such bacteria prove to be challenging to treat; they require more advanced, expensive interventions, and the period of risk of mortality and morbidity is extended.

Counteracting AMR in Neonatal Care

To combat AMR and reduce neonatal mortality a multifaceted approach is necessary. Dr. Taduri emphasizes the continuation of the strategies outlined by the Indian Newborn Action Plan (INAP), specifically in reducing neonatal sepsis and improving infection control. However, to combat AMR more must be done to ensure proper use of antibiotics in both maternal and neonatal care settings.

Key strategies for reducing AMR in neonatal care are:

1. Improving Infection Prevention Practice: This implies, therefore, that more efforts would be made regarding stricter hospital hygiene standards, strict equipment sterilization after its usage and even maintaining adequate hand hygiene. Enhanced infection control practices greatly impact minimizing AMR pathogens distribution.

2. Antibiotic Stewardship- Teaching the healthcare providers how not to use antibiotics is a crucial thing in preventing overuse prescription. Antibiotic stewardship programs are designed to promote use of antibiotics only when truly required; appropriate drug, dose and length of treatment should be taken.

3. Improved access to WASH: Access to clean water and sanitation is a fundamental aspect of preventing infections in mothers and newborns. WASH interventions such as clean birthing practices, can reduce the risk of neonatal sepsis due to unsanitary conditions.

4. Maternal Health Strengthening: Proper maternal care, such as proper vaccination, antenatal steroids, and supplementation of micronutrients, can reduce the risk of prematurity and neonatal infection. Prevention of infection in mothers is the first step towards prevention of infection in newborns.

5. Early Diagnosis and Treatment: Early identification and treatment of neonatal infections are very important. This includes proper screening for sepsis and the use of appropriate antibiotics based on the local resistance patterns. It also involves ensuring that infants receive adequate neonatal care, such as those provided in Special Newborn Care Units (SNCUs).

The rise of antimicrobial resistance is a global health challenge that requires urgent action. Combating AMR requires a coordinated effort from governments, healthcare systems and communities worldwide. In neonatal care, addressing AMR is essential to further reducing neonatal mortality rates and ensuring that every newborn has the opportunity to thrive.

As Dr. Taduri concludes, "While we have made substantial progress in reducing neonatal mortality, the emerging risk of antimicrobial resistance creates a major challenge for our efforts. Combating AMR requires a global collective effort, with priorities on infection prevention, responsible use of antibiotics, and enhancement of healthcare practices to ensure a healthier future for all newborns."

Dr Apoorva Taduri is a Consultant Neonatologist at Fernandez Hospital

End of Article

Trying For A Baby? Tobacco Smoking Hurting Male And Female Fertility, Warns WHO

Updated Sep 9, 2026 | 06:00 PM IST

SummaryFor men, cigarette smoking is associated with harmful effects on semen and sperm, as well as sexual function, which can contribute to infertility. ​Women who quit smoking may have a lower risk of infertility compared with women who continue to smoke.
Trying For A Baby? Tobacco Smoking Hurting Male And Female Fertility, Warns WHO

Credit: iStock

Globally, one in six people of reproductive age experiences infertility at some point in their lifetime. Smoking is one of the key reasons for infertility among men and women worldwide, according to a new World Health Organization (WHO) knowledge summary.

The report, the 12th in a series of Tobacco Knowledge Summaries, highlights evidence linking tobacco use to infertility in women, harmful effects on sperm and sexual function in men, and potentially lower chances of success with some fertility treatments. It also warns that second-hand smoke may affect reproductive health.

Infertility is defined as the failure to achieve pregnancy after 12 months or more of regular unprotected sex.

What Does the WHO Report Say?

Infertility can have multiple causes. However, cigarette smoking and exposure to second-hand tobacco smoke are associated with infertility in women.

The harmful effects of cigarette smoking on women’s reproductive health are well documented, while evidence on other tobacco products, including waterpipe and smokeless tobacco, as well as nicotine products such as e-cigarettes, is still emerging.

Current data suggest potential risks to fertility, but further research is needed to fully understand these effects. Among

men, cigarette smoking is associated with harmful effects on semen and sperm, as well as sexual function, which can contribute to infertility.

On the other hand, women who quit smoking may have a lower risk of infertility compared with women who continue to smoke.

WHO recommends that healthcare providers inform individuals and couples planning pregnancy about the reproductive risks of tobacco use and offer evidence-based support to help them quit.

How Smoking Affects Fertility?

“Smoking is an important fertility consideration for both men and women. It can affect the quality of both eggs and sperm, and the concern is not limited to people who smoke themselves,” Dr Neelam Suri, Senior Consultant, Obstetrics & Gynecology, Indraprastha Apollo Hospital, Delhi, told HealthandMe.

Smoking also accelerates follicular depletion, which may contribute to an earlier onset of menopause compared with women who do not smoke.

Second-hand smoke can expose individuals to harmful substances that may affect reproductive health. Eggs and sperm are rapidly developing cells, and exposure to tobacco smoke can increase the risk of DNA damage and other cellular changes that may affect fertility and reproductive outcomes.

Dr Shalu , Senior Clinical Director, Cloudnine Group of Hospitals, Gurugram, told HealthandMe that while passive smoking may not directly cause infertility in every individual, regular exposure to tobacco smoke can affect reproductive health and have significant implications during pregnancy.

These include ectopic pregnancy, miscarriage, preterm birth, pre-eclampsia, fetal growth restriction, low birth weight, stillbirth, placental complications and neonatal complications.

Regular exposure to second-hand smoke may also potentially influence the chances of success with fertility treatments such as IVF.

“This is particularly relevant for couples undergoing IVF, where egg and sperm quality can influence the chances of successful treatment,” Dr Suri said.

What Should Couples Planning Pregnancy Do?

For couples planning a pregnancy or undergoing fertility treatment, avoiding tobacco smoke is an important step towards protecting reproductive health.

This means quitting smoking and maintaining a smoke-free environment at home to reduce regular exposure to cigarette smoke.

At the same time, fertility depends on multiple factors. Exposure to second-hand smoke does not necessarily mean a couple will experience infertility or IVF failure. However, reducing preventable risk factors can be beneficial when trying to conceive.

Ideally, couples should create a smoke-free environment before conception rather than waiting until fertility difficulties emerge.

End of Article

Could Tylenol Taken During Pregnancy Affect Girl Child’s Future Reproductive Health? Study Raises Concern

Updated Sep 9, 2026 | 04:00 PM IST

SummaryA recent study indicates that Tylenol taken during pregnancy may result in smaller ovaries and uterus in her girl child after infancy and during adolescence.
Could Tylenol Taken During Pregnancy Affect Girl Child’s Future Reproductive Health? Study Raises Concern

Credit: X

Tylenol is one of the most commonly used pain killers. That’s why a study on the drug’s long-term effect on reproductive health of unborn girl children is concerning.

Researchers in Denmark found that girls exposed to paracetamol, also known as acetaminophen or Tylenol in the US, during fetal development had smaller ovaries, fewer ovarian follicles and smaller uteruses in infancy compared to girls who were not exposed to the component.

It’s essential to understand that study does not show that girls exposed to the drug will certainly have fertility problems later in life.

The researchers say it is still too early to know whether the changes observed during infancy and adolescence will translate into reduced fertility or earlier menopause.

What Did The Study Find?

Published in Human Reproduction Open, the study involved 302 girls from the Copenhagen Analgesic Study, or COPANA.

The researchers tracked mothers' paracetamol use during pregnancy through repeated questionnaires and also measured the drug in urine samples.

The girls were examined at around three months of age, during a period known as minipuberty, when the reproductive hormone system becomes temporarily active.

Of the 302 girls, 92 had first been exposed to paracetamol before 17 weeks of pregnancy; 67 were first exposed from 17 weeks onward and 143 had no reported prenatal exposure.

The researchers found that girls exposed during early fetal development had an approximately 40% smaller ovarian volume and a 13% smaller uterine volume compared to girls who were not exposed.

Girls exposed during mid-to-late fetal development stage had about 23% fewer ovarian follicles. These follicles contain immature eggs that can potentially develop and mature over a woman's reproductive life.

Additionally, girls exposed exclusively during early pregnancy also had lower levels of anti-Müllerian hormone (AMH), a hormone produced by ovarian follicles that is commonly used as a marker of ovarian reserve.

Also read: Tylenol, Other Medications Linked To 400% Rise In Liver Injuries In US

Changes From Infancy To Adolescence

Researchers also examined an independent group of 1,210 girls who had been followed from infancy through adolescence.

In this group, prenatal paracetamol exposure was associated with a smaller uterus at puberty and smaller ovaries during adolescence.

Study leader Margit Bistrup Fischer of Rigshospitalet in Copenhagen stressed that the long-term implications remain unknown. Whether these early reproductive differences affect fertility or the timing of menopause will require long-term follow-up.

Also read: Lower Doses Of CBD Could Also Cause Liver Damage: FDA Study Finds

Tylenol And Infertility

This was an observational study, which means that researchers looked at an association between prenatal exposure to paracetamol and changes in future reproductive health.

They did not randomly assign pregnant women to take paracetamol, so the study cannot establish that the drug itself caused the changes.

The authors also say that external factors cannot be completely excluded. Women who took paracetamol because they must have been pain and discomfort due to headaches, fever or other illnesses. These underlying conditions could also influence fetal development.

Also, the women used relatively low to moderate amounts of paracetamol. According to COPANA cohort, the most common reasons were headaches or migraines, musculoskeletal pain, illness or cold and fever.

The study also found that increased reported paracetamol exposure, meaning high dose, was too associated with lower ovarian and uterine volumes.

Also read: Paracetamol Is Not Safe For Older People, Finds Study

Earlier Studies That Raised Similar Concerns About Tylenol

It's not the first time that Tylenol has sparked safety concerns. In 2025, new studies by Mount Sinai and Harvard T.H. Chan School of Public Health raised an concerning question: is prenatal exposure to acetaminophen associated with neurodevelopmental disorders including autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children?

A study led by Andrea Baccarelli, dean of Harvard T.H. Chan School of Public Health’s faculty of environmental health in BMC Environmental Health, systematically reviewed 46 previous studies encompassing data from more than 100,000 participants.

The aim was to investigate whether acetaminophen use during pregnancy correlates with neurodevelopmental disorders in children.

Applying the Navigation Guide Systematic Review method—a strict, gold-standard approach to assessing environmental health evidence—the study team evaluated the quality, risk of bias, and strength of evidence of all included research.

By doing so, it was possible to conduct a solid synthesis of available scientific literature, and what emerged was a pattern: better-quality studies showed a more pronounced association between prenatal acetaminophen exposure and offspring increased risk of ADHD and autism.

Another recent study observed that liver injuries reported to US poison centres increased by nearly 400% between 2000 and 2024, due to acetaminophen, sold under brand names like Tylenol.

The study also found that exposures involving acetaminophen-containing combination drugs decreased by 60%-85% after the US Food and Drug Administration capped the amount of acetaminophen allowed in combination prescription products.

However, harmful exposures to acetaminophen alone increased steadily over the 24 years. The findings suggest that regulatory action reduced liver injuries linked to combination products, while acetaminophen alone remained a leading contributor to poison-centre-reported liver injuries.

End of Article

Are Children Breathing Clean Air Inside Classrooms? New European Study Raises Concern

Updated Sep 9, 2026 | 01:06 PM IST

SummaryA recent study conducted across 22 European countries has observed that two specific types of bacteria found in classroom dust could reduce lung function in children.
Are Children Breathing Clean Air Inside Classrooms? New European Study Raises Concern

Credit: AI

Are your kids completely safe inside the classroom? A new study has raised concerns about the air quality in classrooms, particularly the bacteria that could result in reduced lung function in children.

Recent research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain intended to ensure that schools have completely healthy environments for children, particularly their developing lungs.

Classrooms Have High Levels Of Two Harmful Bacteria Groups

The study was presented by Dr. Soutrik Banerjee from the Department of Environmental and Prevention Sciences, University of Ferrara, Italy, and French technology company, Alten S.A.

Researchers from the University of Ferrara in Italy and French technology company Alten analysed data from the SINPHONIE project, which examined indoor environmental conditions in multiple schools across Europe.

The analysis is based on nearly 300 classrooms across 22 European countries. Researchers measured the levels of Streptomyces and Mycobacterium in classroom dust and compared this with lung function in children using spirometry, a standard test to measure breathing and respiration health.

The researchers adjusted their analysis for several factors that could affect lung function, including children's age, sex, body mass index, exposure to second-hand smoke, pet allergens, socioeconomic factors, age of the school building, region and local outdoor air pollution.

They found that children in classrooms with higher levels of Streptomyces had a 0.08-litre lower forced vital capacity (FVC).

Also read: 6-Year-Old Australian Kid Dies From Rarely Seen ‘19th Century Disease’: Why Is Scurvy Still A Risk Today?

What Is Forced Vital Capacity?

Meanwhile, higher levels of Mycobacterium were associated with a 0.06-litre lower FEV₁ and a 0.13-litre-per-second lower peak expiratory flow (PEF). FEV₁ measures how much air can be exhaled in the first second of a forceful breath, while PEF measures the fastest rate at which air can be expelled.

Dr Banerjee told the Congress, “We know that indoor air quality in schools can be affected by pollutants, humidity, ventilation, temperature, dampness and biological agents like fungi and bacteria. However, much less is known about whether the types of bacteria growing in classroom dust are linked to children’s lung function.”

“We were particularly interested in two bacterial groups, Streptomyces and Mycobacterium spp., which are found in soil, dust and water systems. We wanted to see whether higher exposure to these bacteria in the classroom is associated with children’s lung health across Europe.”

Also read: US Newborns Are Missing A Crucial Vitamin K Shot Which Can Lead To Brain Bleeding

How Dangerous Are These Bacteria?

Both Streptomyces and Mycobacterium are present widespread in the environment. They are found in soil, dust and water systems. The study did not show that children developed a bacterial disease because of classroom exposure.

Instead, researchers are investigating whether exposure to the bacteria could influence the airways and thereby their lung function.

One possibility is that they could irritate the respiratory tract or activate immune and inflammatory pathways. Another is that the bacteria may simply be markers of other problems inside a classroom, like excess moisture, poor ventilation, inadequate cleaning or outdoor dust entering the building.

Dr Soutrik Banerjee, from the University of Ferrara, said: “The bacteria may either have a direct biological effect, or they may be indicators of other indoor environmental factors that influence lung function.”

A small reduction in a lung function measurement does not automatically mean that a child has lung disease. Lung function naturally varies between children according to age, height, sex and other factors. The differences reported in this study were modest for individual children, according to the researchers.

However, Banerjee said the findings could still matter at a population level because children are repeatedly exposed to school environments. “Children are exposed to school indoor environments every weekday, and a mild to moderate reduction in lung function today may be a precursor to preventable lung disease in later life,” he said.

How Can This Be Prevented?

The European Respiratory Society specifically cautioned against taking extreme measures like sterilising classrooms.

Professor Alexander Möller, Head of the ERS Paediatric Assembly and Professor of Paediatric Pulmonology at the University Children's Hospital Zurich, who was not involved in the study, said: “The practical message is not that schools should become sterile environments.”

But he pointed that adequate ventilation, control of dampness and mould, regular cleaning and proper building maintenance could help.

End of Article